{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:14:46Z","timestamp":1792239286604,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T00:00:00Z","timestamp":1479686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1038\/onc.2016.412","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T11:04:50Z","timestamp":1479726290000},"page":"2565-2576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer"],"prefix":"10.1038","volume":"36","author":[{"given":"C","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Karnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Tadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Mau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"New","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R J","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gunewardena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A K","family":"Godwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O W","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K F","family":"Roby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Krieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,21]]},"reference":[{"key":"BFonc2016412_CR1","unstructured":"ACS American Cancer Society: Cancer Facts and Figures 2015. American Cancer Society: Atlanta, GA, 2015."},{"key":"BFonc2016412_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","volume":"16","author":"R Vang","year":"2009","unstructured":"Vang R, Shih IeM, Kurman RJ . Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol 2009; 16: 267\u2013282.","journal-title":"Adv Anat Pathol"},{"key":"BFonc2016412_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nrc1611","volume":"5","author":"H Naora","year":"2005","unstructured":"Naora H, Montell DJ . Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 2005; 5: 355\u2013366.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2016412_CR4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E . Ovarian cancer development and metastasis. Am J Pathol 2010; 177: 1053\u20131064.","journal-title":"Am J Pathol"},{"key":"BFonc2016412_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","volume":"33","author":"GL Semenza","year":"2012","unstructured":"Semenza GL . Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 2012; 33: 207\u2013214.","journal-title":"Trends Pharmacol Sci"},{"key":"BFonc2016412_CR6","first-page":"1661","volume":"7","author":"P Birner","year":"2001","unstructured":"Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G . Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res 2001; 7: 1661\u20131668.","journal-title":"Clin Cancer Res"},{"key":"BFonc2016412_CR7","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1371\/journal.pmed.0030047","volume":"3","author":"JT Chi","year":"2006","unstructured":"Chi JT, Wang Z, Nuyten DS, Rodriguez EH, Schaner ME, Salim A et al. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med 2006; 3: e47.","journal-title":"PLoS Med"},{"key":"BFonc2016412_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1042\/BJ20081238","volume":"416","author":"PJ Pollard","year":"2008","unstructured":"Pollard PJ, Loenarz C, Mole DR, McDonough MA, Gleadle JM, Schofield CJ et al. Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha. Biochem J 2008; 416: 387\u2013394.","journal-title":"Biochem J"},{"key":"BFonc2016412_CR9","doi-asserted-by":"publisher","first-page":"36542","DOI":"10.1074\/jbc.M804578200","volume":"283","author":"S Beyer","year":"2008","unstructured":"Beyer S, Kristensen MM, Jensen KS, Johansen JV, Staller P . The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J Biol Chem 2008; 283: 36542\u201336552.","journal-title":"J Biol Chem"},{"key":"BFonc2016412_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1128\/MCB.00444-09","volume":"30","author":"AJ Krieg","year":"2010","unstructured":"Krieg AJ, Rankin EB, Chan D, Razorenova O, Fernandez S, Giaccia AJ . Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth. Mol Cell Biol 2010; 30: 344\u2013353.","journal-title":"Mol Cell Biol"},{"key":"BFonc2016412_CR11","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1073\/pnas.0810067106","volume":"106","author":"X Xia","year":"2009","unstructured":"Xia X, Lemieux ME, Li W, Carroll JS, Brown M, Liu XS et al. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc Natl Acad Sci USA 2009; 106: 4260\u20134265.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2016412_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cell.2006.03.028","volume":"125","author":"JR Whetstine","year":"2006","unstructured":"Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 2006; 125: 467\u2013481.","journal-title":"Cell"},{"key":"BFonc2016412_CR13","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.bbrc.2008.05.150","volume":"372","author":"S Wellmann","year":"2008","unstructured":"Wellmann S, Bettkober M, Zelmer A, Seeger K, Faigle M, Eltzschig HK et al. Hypoxia upregulates the histone demethylase JMJD1A via HIF-1. Biochem Biophys Res Commun 2008; 372: 892\u2013897.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2016412_CR14","doi-asserted-by":"publisher","first-page":"7570","DOI":"10.1158\/0008-5472.CAN-10-1267","volume":"70","author":"EB Rankin","year":"2010","unstructured":"Rankin EB, Fuh KC, Taylor TE, Krieg AJ, Musser M, Yuan J et al. AXL is an essential factor and therapeutic target for metastatic ovarian cancer. Cancer Res 2010; 70: 7570\u20137579.","journal-title":"Cancer Res"},{"key":"BFonc2016412_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/jnci\/90.6.447","volume":"90","author":"J Yoneda","year":"1998","unstructured":"Yoneda J, Kuniyasu H, Crispens MA, Price JE, Bucana CD, Fidler IJ . Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J Natl Cancer Inst 1998; 90: 447\u2013454.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2016412_CR16","doi-asserted-by":"publisher","first-page":"E2707","DOI":"10.1073\/pnas.1214019109","volume":"109","author":"L Schito","year":"2012","unstructured":"Schito L, Rey S, Tafani M, Zhang H, Wong CC, Russo A et al. Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells. Proc Natl Acad Sci USA 2012; 109: E2707\u2013E2716.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2016412_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2217\/fon.11.46","volume":"7","author":"HE Barker","year":"2011","unstructured":"Barker HE, Erler JT . The potential for LOXL2 as a target for future cancer treatment. Future Oncol 2011; 7: 707\u2013710.","journal-title":"Future Oncol"},{"key":"BFonc2016412_CR18","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1158\/0008-5472.CAN-10-2868","volume":"71","author":"HE Barker","year":"2011","unstructured":"Barker HE, Chang J, Cox TR, Lang G, Bird D, Nicolau M et al. LOXL2-mediated matrix remodeling in metastasis and mammary gland involution. Cancer Res 2011; 71: 1561\u20131572.","journal-title":"Cancer Res"},{"key":"BFonc2016412_CR19","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/nature04695","volume":"440","author":"JT Erler","year":"2006","unstructured":"Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 2006; 440: 1222\u20131226.","journal-title":"Nature"},{"key":"BFonc2016412_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1530\/ERC-11-0329","volume":"19","author":"B Gyorffy","year":"2012","unstructured":"Gyorffy B, Lanczky A, Szallasi Z . Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. Endocr -Relat Cancer 2012; 19: 197\u2013208.","journal-title":"Endocr -Relat Cancer"},{"key":"BFonc2016412_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1146\/annurev.biochem.78.070907.103946","volume":"79","author":"N Mosammaparast","year":"2010","unstructured":"Mosammaparast N, Shi Y . Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu Rev Biochem 2010; 79: 155\u2013179.","journal-title":"Annu Rev Biochem"},{"key":"BFonc2016412_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1741-7007-10-29","volume":"10","author":"M Vinci","year":"2012","unstructured":"Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, Court W et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol 2012; 10: 29.","journal-title":"BMC Biol"},{"key":"BFonc2016412_CR23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.cell.2013.06.051","volume":"154","author":"JC Black","year":"2013","unstructured":"Black JC, Manning AL, Van Rechem C, Kim J, Ladd B, Cho J et al. KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors. Cell 2013; 154: 541\u2013555.","journal-title":"Cell"},{"key":"BFonc2016412_CR24","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1101\/gad.259796.115","volume":"29","author":"JC Black","year":"2015","unstructured":"Black JC, Atabakhsh E, Kim J, Biette KM, Van Rechem C, Ladd B et al. Hypoxia drives transient site-specific copy gain and drug-resistant gene expression. Genes Dev 2015; 29: 1018\u20131031.","journal-title":"Genes Dev"},{"key":"BFonc2016412_CR25","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1093\/nar\/gkt106","volume":"41","author":"K Coffey","year":"2013","unstructured":"Coffey K, Rogerson L, Ryan-Munden C, Alkharaif D, Stockley J, Heer R et al. The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover. Nucleic Acids Res 2013; 41: 4433\u20134446.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2016412_CR26","doi-asserted-by":"publisher","first-page":"6456","DOI":"10.1158\/0008-5472.CAN-10-0413","volume":"70","author":"J Yang","year":"2010","unstructured":"Yang J, Jubb AM, Pike L, Buffa FM, Turley H, Baban D et al. The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth. Cancer Res 2010; 70: 6456\u20136466.","journal-title":"Cancer Res"},{"key":"BFonc2016412_CR27","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1158\/1078-0432.CCR-13-0254","volume":"19","author":"L Zhao","year":"2013","unstructured":"Zhao L, Li W, Zang W, Liu Z, Xu X, Yu H et al. JMJD2B promotes epithelial-mesenchymal transition by cooperating with beta-catenin and enhances gastric cancer metastasis. Clin Cancer Res 2013; 19: 6419\u20136429.","journal-title":"Clin Cancer Res"},{"key":"BFonc2016412_CR28","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1158\/0008-5472.CAN-12-4300","volume":"73","author":"WL Berry","year":"2013","unstructured":"Berry WL, Janknecht R . KDM4\/JMJD2 histone demethylases: epigenetic regulators in cancer cells. Cancer Res 2013; 73: 2936\u20132942.","journal-title":"Cancer Res"},{"key":"BFonc2016412_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ygyno.2003.12.041","volume":"93","author":"SM Apte","year":"2004","unstructured":"Apte SM, Bucana CD, Killion JJ, Gershenson DM, Fidler IJ . Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines. Gynecol Oncol 2004; 93: 78\u201386.","journal-title":"Gynecol Oncol"},{"key":"BFonc2016412_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ijc.20408","volume":"112","author":"AD Santin","year":"2004","unstructured":"Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Bignotti E et al. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int J Cancer 2004; 112: 14\u201325.","journal-title":"Int J Cancer"},{"key":"BFonc2016412_CR31","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4161\/cbt.9.3.10635","volume":"9","author":"C Lu","year":"2010","unstructured":"Lu C, Shahzad MM, Moreno-Smith M, Lin YG, Jennings NB, Allen JK et al. Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models. Cancer Biol Ther 2010; 9: 176\u2013182.","journal-title":"Cancer Biol Ther"},{"key":"BFonc2016412_CR32","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1095\/biolreprod.110.088955","volume":"84","author":"N Iwamori","year":"2011","unstructured":"Iwamori N, Zhao M, Meistrich ML, Matzuk MM . The testis-enriched histone demethylase, KDM4D, regulates methylation of histone H3 lysine 9 during spermatogenesis in the mouse but is dispensable for fertility. Biol Reprod 2011; 84: 1225\u20131234.","journal-title":"Biol Reprod"},{"key":"BFonc2016412_CR33","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1101\/gad.280495.116","volume":"30","author":"K Agger","year":"2016","unstructured":"Agger K, Miyagi S, Pedersen MT, Kooistra SM, Johansen JV, Helin K . Jmjd2\/Kdm4 demethylases are required for expression of Il3ra and survival of acute myeloid leukemia cells. Genes Dev 2016; 30: 1278\u20131288.","journal-title":"Genes Dev"},{"key":"BFonc2016412_CR34","doi-asserted-by":"publisher","first-page":"6060","DOI":"10.1074\/jbc.M115.696864","volume":"291","author":"LR Pack","year":"2016","unstructured":"Pack LR, Yamamoto KR, Fujimori DG . Opposing chromatin signals direct and regulate the activity of lysine demethylase 4C (KDM4C). J Biol Chem 2016; 291: 6060\u20136070.","journal-title":"J Biol Chem"},{"key":"BFonc2016412_CR35","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/emboj.2012.47","volume":"31","author":"FA Mallette","year":"2012","unstructured":"Mallette FA, Mattiroli F, Cui G, Young LC, Hendzel MJ, Mer G et al. RNF8- and RNF168-dependent degradation of KDM4A\/JMJD2A triggers 53BP1 recruitment to DNA damage sites. EMBO J 2012; 31: 1865\u20131878.","journal-title":"EMBO J"},{"key":"BFonc2016412_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1042\/BJ20121155","volume":"449","author":"EM Sanchez-Fernandez","year":"2013","unstructured":"Sanchez-Fernandez EM, Tarhonskaya H, Al-Qahtani K, Hopkinson RJ, McCullagh JS, Schofield CJ et al. Investigations on the oxygen dependence of a 2-oxoglutarate histone demethylase. Biochem J 2013; 449: 491\u2013496.","journal-title":"Biochem J"},{"key":"BFonc2016412_CR37","doi-asserted-by":"publisher","first-page":"7541","DOI":"10.1073\/pnas.1017374108","volume":"108","author":"L Shi","year":"2011","unstructured":"Shi L, Sun L, Li Q, Liang J, Yu W, Yi X et al. Histone demethylase JMJD2B coordinates H3K4\/H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc Natl Acad Sci USA 2011; 108: 7541\u20137546.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2016412_CR38","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nrd4154","volume":"12","author":"JW Hojfeldt","year":"2013","unstructured":"Hojfeldt JW, Agger K, Helin K . Histone lysine demethylases as targets for anticancer therapy. Nat Rev Drug Discov 2013; 12: 917\u2013930.","journal-title":"Nat Rev Drug Discov"},{"key":"BFonc2016412_CR39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.coph.2015.05.009","volume":"23","author":"T Maes","year":"2015","unstructured":"Maes T, Carceller E, Salas J, Ortega A, Buesa C . Advances in the development of histone lysine demethylase inhibitors. Curr Opin Pharmacol 2015; 23: 52\u201360.","journal-title":"Curr Opin Pharmacol"},{"key":"BFonc2016412_CR40","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nature11262","volume":"488","author":"L Kruidenier","year":"2012","unstructured":"Kruidenier L, Chung CW, Cheng Z, Liddle J, Che K, Joberty G et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 2012; 488: 404\u2013408.","journal-title":"Nature"},{"key":"BFonc2016412_CR41","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrrheum.2012.36","volume":"8","author":"C Maes","year":"2012","unstructured":"Maes C, Carmeliet G, Schipani E . Hypoxia-driven pathways in bone development, regeneration and disease. Nat Rev Rheumatol 2012; 8: 358\u2013366.","journal-title":"Nat Rev Rheumatol"},{"key":"BFonc2016412_CR42","volume-title":"Discovery of ML324, a JMJD2 demethylase inhibitor with demonstrated antiviral activity","author":"G Rai","year":"2010","unstructured":"Rai G, Kawamura A, Tumber A, Liang Y, Vogel JL, Arbuckle JH et al. Discovery of ML324, a JMJD2 demethylase inhibitor with demonstrated antiviral activity. Probe Reports from the NIH Molecular Libraries Program: Bethesda, MD, 2010."},{"key":"BFonc2016412_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1039\/C0OB00592D","volume":"9","author":"A Thalhammer","year":"2011","unstructured":"Thalhammer A, Mecinovic J, Loenarz C, Tumber A, Rose NR, Heightman TD et al. Inhibition of the histone demethylase JMJD2E by 3-substituted pyridine 2, 4-dicarboxylates. Org Biomol Chem 2011; 9: 127\u2013135.","journal-title":"Org Biomol Chem"},{"key":"BFonc2016412_CR44","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1021\/acschembio.6b00080","volume":"11","author":"G Joberty","year":"2016","unstructured":"Joberty G, Boesche M, Brown JA, Eberhard D, Garton NS, Humphreys PG et al. Interrogating the Druggability of the 2-Oxoglutarate-Dependent Dioxygenase Target Class by Chemical Proteomics. ACS Chem Biol 2016; 11: 2002\u20132010.","journal-title":"ACS Chem Biol"},{"key":"BFonc2016412_CR45","doi-asserted-by":"publisher","first-page":"21376","DOI":"10.1074\/jbc.M113.491514","volume":"288","author":"LC Young","year":"2013","unstructured":"Young LC, McDonald DW, Hendzel MJ . Kdm4b histone demethylase is a DNA damage response protein and confers a survival advantage following gamma-irradiation. J Biol Chem 2013; 288: 21376\u201321388.","journal-title":"J Biol Chem"},{"key":"BFonc2016412_CR46","doi-asserted-by":"publisher","first-page":"e6529","DOI":"10.1371\/journal.pone.0006529","volume":"4","author":"E Campeau","year":"2009","unstructured":"Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO et al. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One 2009; 4: e6529.","journal-title":"PLoS One"},{"key":"BFonc2016412_CR47","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1158\/1055-9965.EPI-11-0455","volume":"20","author":"EL Goode","year":"2011","unstructured":"Goode EL, Chenevix-Trench G, Hartmann LC, Fridley BL, Kalli KR, Vierkant RA et al. Assessment of hepatocyte growth factor in ovarian cancer mortality. Cancer Epidemiol Biomarkers Prev 2011; 20: 1638\u20131648.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFonc2016412_CR48","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","volume":"4","author":"RA Irizarry","year":"2003","unstructured":"Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249\u2013264.","journal-title":"Biostatistics"},{"key":"BFonc2016412_CR49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y . Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Roy Stat Soc B Met 1995; 57: 289\u2013300.","journal-title":"J Roy Stat Soc B Met"},{"key":"BFonc2016412_CR50","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30: 207\u2013210.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2016412_CR51","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1101\/gad.1471106","volume":"20","author":"SM Welford","year":"2006","unstructured":"Welford SM, Bedogni B, Gradin K, Poellinger L, Broome Powell M, Giaccia AJ . HIF1alpha delays premature senescence through the activation of MIF. Genes Dev 2006; 20: 3366\u20133371.","journal-title":"Genes Dev"},{"key":"BFonc2016412_CR52","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ki.2012.446","volume":"83","author":"KI Swenson-Fields","year":"2013","unstructured":"Swenson-Fields KI, Vivian CJ, Salah SM, Peda JD, Davis BM, van Rooijen N et al. Macrophages promote polycystic kidney disease progression. Kidney Int 2013; 83: 855\u2013864.","journal-title":"Kidney Int"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/onc2016412","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2016412.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2016.412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/onc2016412.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T18:30:28Z","timestamp":1718908228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2016412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,21]]},"references-count":52,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["BFonc2016412"],"URL":"https:\/\/doi.org\/10.1038\/onc.2016.412","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,21]]},"assertion":[{"value":"8 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}